tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CGEM Stock Latest News

Cullinan Management’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
RatingsCullinan Management’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
8d ago
CGEM
Cullinan Therapeutics Reports Increased Q3 Losses
PremiumCompany Announcements
Cullinan Therapeutics Reports Increased Q3 Losses
13d ago
CGEM
Cullinan Management: Strong Financials and Promising Pipeline Justify Buy Rating
PremiumRatings
Cullinan Management: Strong Financials and Promising Pipeline Justify Buy Rating
13d ago
CGEM
Cullinan Management’s Promising Pipeline and Strategic Focus Earns Buy Rating
PremiumRatings
Cullinan Management’s Promising Pipeline and Strategic Focus Earns Buy Rating
13d ago
CGEM
Cullinan Management Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Cullinan Management Reports Strong Q3 2025 Financial Results
13d ago
8K
CGEM
Cullinan Therapeutics reports Q3 EPS (77c), consensus (89c)
PremiumThe FlyCullinan Therapeutics reports Q3 EPS (77c), consensus (89c)
13d ago
CGEM
Promising Phase 1 Results for CLN-049 in AML Justify Buy Rating
Premium
Ratings
Promising Phase 1 Results for CLN-049 in AML Justify Buy Rating
16d ago
CGEM
Cullinan Management Unveils Promising CLN-049 Clinical Data
Premium
Company Announcements
Cullinan Management Unveils Promising CLN-049 Clinical Data
16d ago
8K
CGEM
Cullinan Therapeutics to showcase new data from Phase 1 study of CLN-049
PremiumThe Fly
Cullinan Therapeutics to showcase new data from Phase 1 study of CLN-049
16d ago
CGEM
Promising Clinical Trial Results and Strategic Partnerships Drive Buy Rating for Cullinan Management
PremiumRatings
Promising Clinical Trial Results and Strategic Partnerships Drive Buy Rating for Cullinan Management
1M ago
CGEM
Buy Rating for Cullinan Management’s Zipalertinib: Promising Efficacy in Challenging EGFR Mutated NSCLC Cases
PremiumRatings
Buy Rating for Cullinan Management’s Zipalertinib: Promising Efficacy in Challenging EGFR Mutated NSCLC Cases
1M ago
CGEM
Promising Efficacy of Zipalertinib in EGFR NSCLC with CNS Involvement Justifies Buy Rating for Cullinan Management
PremiumRatings
Promising Efficacy of Zipalertinib in EGFR NSCLC with CNS Involvement Justifies Buy Rating for Cullinan Management
1M ago
CGEM
Promising Developments in Cullinan Management’s Zipalertinib Drive Buy Rating
PremiumRatingsPromising Developments in Cullinan Management’s Zipalertinib Drive Buy Rating
1M ago
CGEM
Promising Trial Results and Strategic Plans Justify Buy Rating for Cullinan Management
Premium
Ratings
Promising Trial Results and Strategic Plans Justify Buy Rating for Cullinan Management
2M ago
CGEM
Positive Buy Rating for Cullinan Management Driven by Promising Zipalertinib Trial Results in NSCLC with Uncommon EGFR Mutations
Premium
Ratings
Positive Buy Rating for Cullinan Management Driven by Promising Zipalertinib Trial Results in NSCLC with Uncommon EGFR Mutations
2M ago
CGEM
Promising Drug Pipeline and Strategic Collaborations Drive Buy Rating for Cullinan Management
PremiumRatings
Promising Drug Pipeline and Strategic Collaborations Drive Buy Rating for Cullinan Management
2M ago
CGEM
Cullinan Management’s Strategic Adjustments and Pipeline Development Justify Buy Rating
PremiumRatings
Cullinan Management’s Strategic Adjustments and Pipeline Development Justify Buy Rating
2M ago
CGEM
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
PremiumMarket News
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
3M ago
CGEM
TECX
Promising Potential of Cullinan Management’s CLN-978 Therapy Drives Buy Rating
PremiumRatings
Promising Potential of Cullinan Management’s CLN-978 Therapy Drives Buy Rating
3M ago
CGEM
Cullinan Management: Strategic Positioning and Growth Potential Justify Buy Rating Despite Study Delay
PremiumRatingsCullinan Management: Strategic Positioning and Growth Potential Justify Buy Rating Despite Study Delay
3M ago
CGEM
Cullinan Management: Promising Growth Amid SLE Trial Delay with Strong Pipeline and Strategic Focus
Premium
Ratings
Cullinan Management: Promising Growth Amid SLE Trial Delay with Strong Pipeline and Strategic Focus
3M ago
CGEM
Cullinan Management Updates Strategic Goals and Timeline
Premium
Company Announcements
Cullinan Management Updates Strategic Goals and Timeline
3M ago
8K
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >